全球抗栓襪市場

預計 2030 年全球抗栓襪市場規模將達 9.738 億美元

全球抗栓塞襪市場規模預計在2024年為7.707億美元，到2030年將達到9.738億美元，在2024-2030年的分析期間內，複合年成長率為4.0%。小腿長度的抗栓塞襪是本報告分析的細分市場之一，預計其複合年成長率為4.8%，到分析期結束時將達到6.142億美元。大腿長度的抗栓塞襪細分市場在分析期間的複合年成長率預計為2.7%。

美國市場預計將達到 2.1 億美元，而中國市場預計將以 7.5% 的複合年成長率成長

美國抗栓襪市場規模預計2024年達到2.1億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到1.994億美元，在分析期間（2024-2030年）的複合年成長率為7.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.6%和3.1%。在歐洲，預計德國市場的複合年成長率為2.3%。

全球抗栓塞襪市場－主要趨勢與促進因素摘要

為什麼抗栓塞襪成為術後和臥床患者照護的重要一環？

抗栓塞襪已成為預防靜脈血栓栓塞症(VTE) 的重要工具，尤其適用於接受手術或臥床不起的患者。這些專用襪旨在對下肢施加漸進式壓力，透過將靜脈血推回心臟來促進血液循環，防止血液淤滯（血栓形成的主要原因）。這些襪子的作用在醫院環境中尤其重要，因為在大型手術、創傷和長期復原期間的不動會顯著增加深層靜脈栓塞症(DVT) 和肺動脈栓塞(PE) 的風險。各學科的醫療保健提供者現在都將抗栓塞襪視為高風險患者的標準護理，通常與抗凝血治療結合使用以減少併發症。術後患者，尤其是從整形外科、腹部和心血管手術中恢復的患者，可能在幾天甚至幾週內活動受限，因此使用抗栓塞襪將大有裨益。此外，它們也被廣泛推薦用於加護病房(ICU)、老年病房和復健中心的病人。隨著醫院越來越注重患者的治療效果和安全，降低深部靜脈栓塞 (DVT) 等醫院內感染的發生率已成為當務之急，這促使抗栓襪得到廣泛應用。抗栓襪的成本效益、易用性和非侵入性使其成為住院和門診病人的理想選擇。在許多情況下，這些襪的使用是由機構通訊協定和/或醫療保險提供者強制要求的，這進一步鞏固了它們在現代預防醫學中的作用。

哪些醫療和材料創新使抗栓塞襪更有效？

醫用紡織品和壓力技術的最新進展顯著提高了抗栓襪的舒適度、功效和依從性。過去，不適感、尺寸不合適以及穿脫困難限制了患者的依從性。現今的襪子採用透氣、低致敏性和抗菌材料製成，可減少皮膚刺激，並可在不影響衛生的情況下延長穿著時間。漸進式壓力技術也得到了發展，可以精確控制壓力等級，通常在腳踝處壓力最高，並逐漸向大腿方向降低，以最佳化靜脈回流，同時不會限制活動或損傷組織。無縫針織和人體工學設計改善了人體結構貼合度，提高了治療效果和穿著舒適度。有些襪子現在採用了能夠調節體溫的智慧纖維，這對於在不同氣候條件下長期穿著尤其有益。此外，顏色編碼的尺寸系統和增強的彈性簡化了產品選擇，並降低了因使用不當而導致的風險。 3D人體掃描儀和行動應用程式等數位工具正被用於輔助精準試穿，尤其是在門診病人中。同時，嵌入感測器的彈性襪的研究也正在進行中，這種彈性襪可以即時監測靜脈壓力和運動，並有可能將這些服裝轉化為診斷工具。這些技術創新正在提高抗栓塞彈性襪的臨床和功能標準，確保患者更順暢地服藥並改善治療效果，從而為更廣泛的醫療保健場景開闢應用前景。

全球人口趨勢和醫療保健如何推動抗栓塞襪市場？

宏觀人口結構的變化和不斷發展的醫療保健服務模式正在塑造全球抗栓塞襪市場。與老齡化相關的靜脈功能不全、行動不便和外科手術的盛行率顯著升高，尤其是在北美、歐洲和亞洲部分地區。老年人更容易感染靜脈血栓栓塞症 (VTE)，醫生通常會將抗栓塞襪等預防措施作為日常護理的一部分。此外，肥胖、心血管疾病和糖尿病等慢性疾病負擔的增加進一步增加了血栓風險，需要採取主動干預措施。同時，擇期手術（尤其是膝關節和髖關節置換術等整形外科手術）的增多，使得住院和出院後對這些產品的需求持續穩定成長。向門診關節重建和當日出院模式的轉變推動了對患者管理的預防保健的需求，而抗栓塞襪在這些通訊協定中發揮著核心作用。隨著醫療基礎設施的改善和靜脈血栓栓塞 (VTE) 預防意識的提升，新興市場也在推動市場發展。公共衛生宣傳活動和機構強制要求不斷提升深部靜脈血栓 (DVT) 預防的重要性，尤其是在外科和長期照護機構。此外，保險報銷和綜合護理計劃進一步鼓勵使用經濟高效的非藥物預防方法。同時，線上零售通路和電子藥局也讓尋求居家醫療解決方案的消費者更容易獲得彈性襪，並鼓勵其在臨床治療之外的使用。這些人口結構和結構性變化共同作用，正在為全球各級護理機構帶來持續的抗栓彈性襪需求。

全球越來越多採用抗栓塞襪的主要促進因素是什麼？

抗栓塞襪市場的成長受到多種重要因素的驅動，這些因素源自於臨床需求、醫療政策、技術進步和消費行為。其中最重要的因素之一是靜脈血栓栓塞（VTE）發病率的上升，尤其是在住院患者、術後患者和無法活動的患者中。監管機構和專業醫學協會已發布指南，建議將壓迫療法作為標準預防措施，使其在醫學上得到合理認可和機構支持。實證醫學的採用使得醫院廣泛將抗栓塞襪納入其手術恢復通訊協定中，旨在減少併發症、再入院率和相關的醫療成本。另一個主要促進因素是紡織工程的持續進步，這使得製造商能夠生產出不僅更有效而且更易於穿著的襪子，從而提高了患者的依從性和滿意度。遠端醫療和遠距患者管理的日益普及也起到了一定作用，臨床醫生會向在家休養的患者推薦壓力服，尤其是在整形外科和心血管手術後。此外，日益增強的健康意識和積極主動的健康行為促使消費者即使沒有直接處方箋也會購買壓力襪等預防性醫療產品。產品分銷管道急劇擴張，如今可透過藥局、線上平台、醫療供應商甚至健康相關零售商購買。醫療保健提供者與製造商之間的策略夥伴關係，以及針對患者和臨床醫生的教育計劃，進一步推動了其普及。這些因素，加上對早期療育、預防醫學和非侵入性治療方案的重視，鞏固了抗栓襪作為全球現代醫療保健系統基本組成部分的地位。

部分

產品（小腿長度栓塞襪、大腿長度栓塞襪）；人口統計資料（男性、女性）；最終用途（門診病人最終用途、術後患者最終用途、孕婦最終用途、其他最終用途）

調查企業範例（共34家企業）

• 3M Company
• B. Braun Melsungen AG
• BSN Medical GmbH
• Cardinal Health Inc.
• Covidien（Medtronic）
• Essity AB
• Halyard Health Inc.
• Kendall（Covidien）
• Lohmann & Rauscher GmbH
• Medline Industries, Inc.
• Molnlycke Health Care AB
• Paul Hartmann AG
• Prestige Brands Holdings Inc.
• Sanko Medical Co., Ltd.
• Sigvaris AG
• Smith & Nephew plc
• Solidea Srl
• Thermo Fisher Scientific Inc.
• Thuasne Group
• Unomedical（a part of Coloplast）

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自全球領域專家的精選內容庫，其中包括影片記錄、BLOG、搜尋引擎研究以及大量公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Anti-Embolism Stockings Market to Reach US$973.8 Million by 2030

The global market for Anti-Embolism Stockings estimated at US$770.7 Million in the year 2024, is expected to reach US$973.8 Million by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Calf-Length Anti-Embolism Stockings, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$614.2 Million by the end of the analysis period. Growth in the Thigh-Length Anti-Embolism Stockings segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$210.0 Million While China is Forecast to Grow at 7.5% CAGR

The Anti-Embolism Stockings market in the U.S. is estimated at US$210.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$199.4 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Anti-Embolism Stockings Market - Key Trends & Drivers Summarized

Why Are Anti-Embolism Stockings Becoming a Critical Component of Post-Surgical and Bedridden Patient Care?

Anti-embolism stockings have emerged as a crucial tool in the prevention of venous thromboembolism (VTE), particularly for patients undergoing surgery or confined to bed rest. Designed to apply graduated pressure to the lower limbs, these specialized stockings enhance blood circulation by pushing venous blood back toward the heart, thereby preventing stasis-a key contributor to clot formation. Their role has become especially vital in hospital environments where immobility, whether due to major surgery, trauma, or prolonged recovery, significantly elevates the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Healthcare providers across disciplines now consider anti-embolism stockings a standard of care for at-risk patients, often using them in combination with anticoagulant therapies to reduce complications. Postoperative patients, especially those recovering from orthopedic, abdominal, or cardiovascular procedures, benefit enormously from their use, as movement may be restricted for days or even weeks. Moreover, they are widely recommended for patients in intensive care units (ICUs), geriatric wards, and rehabilitation centers. As hospitals increasingly focus on patient outcomes and safety metrics, reducing the incidence of hospital-acquired conditions like DVT has become a top priority-thus driving the widespread use of anti-embolism stockings. Their cost-effectiveness, ease of application, and non-invasive nature make them an attractive option for both inpatient and outpatient settings. In many cases, the use of these stockings is mandated by institutional protocols and health insurance providers, further cementing their role in modern preventive medicine.

What Medical and Material Innovations Are Enhancing the Efficacy of Anti-Embolism Stockings?

Recent advances in medical textiles and compression technology are significantly improving the comfort, effectiveness, and compliance associated with anti-embolism stockings. Historically, patient adherence was limited due to discomfort, improper sizing, or difficulty in donning the stockings-issues that have now been addressed through more sophisticated designs and materials. Today’s stockings are made with breathable, hypoallergenic, and antimicrobial fabrics that reduce skin irritation and allow for prolonged wear without compromising hygiene. Graduated compression technology has also evolved, allowing for precise control over pressure levels-typically highest at the ankle and gradually decreasing toward the thigh-to optimize venous return without constricting movement or causing tissue damage. Seamless knitting techniques and ergonomic designs ensure a better anatomical fit, which not only improves therapeutic outcomes but also enhances user comfort. Some stockings now incorporate smart fibers capable of temperature regulation, which is particularly beneficial for long-term wear in varied climates. In addition, color-coded sizing systems and improved elasticity have simplified product selection and reduced the risk of improper usage. Digital tools such as 3D body scanners and mobile apps are being used to assist with accurate fitting, especially in outpatient scenarios. Meanwhile, research is ongoing into sensor-embedded stockings that can monitor venous pressure or movement in real-time, potentially transforming these garments into diagnostic tools as well. These technological innovations are raising the clinical and functional standards of anti-embolism stockings, ensuring better patient adherence, improved outcomes, and expanding their application across a wider spectrum of medical scenarios.

How Are Global Demographic Trends and Healthcare Practices Expanding the Market for Anti-Embolism Stockings?

The global market for anti-embolism stockings is being shaped by macro-level demographic shifts and evolving healthcare delivery models. A key factor is the aging global population, particularly in regions like North America, Europe, and parts of Asia, where the prevalence of age-related venous insufficiency, limited mobility, and surgical interventions is significantly higher. Older adults are more susceptible to VTE, and preventive measures like anti-embolism stockings are increasingly prescribed as part of routine care. Additionally, the growing burden of chronic diseases such as obesity, cardiovascular conditions, and diabetes further increases the risk of blood clots, necessitating proactive interventions. At the same time, the rising frequency of elective surgeries-particularly orthopedic procedures such as knee and hip replacements-has created a steady demand for these products in both hospital and post-discharge settings. The shift toward outpatient surgery and same-day discharge models has heightened the need for patient-managed preventive care, with anti-embolism stockings playing a central role in these protocols. Developing nations are also contributing to market growth as healthcare infrastructure improves and awareness of VTE prevention increases. Public health campaigns and institutional mandates are reinforcing the importance of DVT prophylaxis, especially in surgical and long-term care environments. Insurance reimbursement and bundled care initiatives are further incentivizing the use of cost-effective, non-pharmacological preventive measures. In parallel, online retail channels and e-pharmacies are making these stockings more accessible to consumers seeking at-home medical solutions, supporting their use beyond the clinical setting. Collectively, these demographic and structural shifts are creating sustained, global demand for anti-embolism stockings across multiple levels of care.

What Are the Core Drivers Behind the Rising Adoption of Anti-Embolism Stockings Worldwide?

The growth in the anti-embolism stockings market is driven by several compelling factors grounded in clinical demand, healthcare policy, technological improvement, and consumer behavior. One of the most critical drivers is the increasing incidence of VTE, particularly among hospitalized, post-surgical, and immobile patients-a demographic that continues to expand with rising hospitalization rates and longer life expectancy. Regulatory agencies and professional medical associations have issued guidelines recommending the use of compression therapy as a standard preventive measure, giving the category both medical legitimacy and institutional support. The adoption of evidence-based medicine has led to widespread incorporation of anti-embolism stockings in surgical recovery protocols, with hospitals aiming to reduce complications, readmissions, and associated healthcare costs. Another major driver is the continuous advancement in textile engineering, allowing manufacturers to create stockings that are not only more effective but also more wearable-leading to better patient compliance and satisfaction. The increasing popularity of telehealth and remote patient management is also contributing, as clinicians recommend compression wear for patients recovering at home, especially after orthopedic or cardiovascular procedures. Moreover, the rise in health awareness and proactive wellness behaviors has encouraged consumers to invest in preventive health products like compression stockings even without a direct prescription. Distribution has expanded dramatically, with products now available via pharmacies, online platforms, medical suppliers, and even wellness retailers. Strategic partnerships between healthcare providers and manufacturers, along with educational initiatives aimed at both patients and clinicians, are further driving adoption. These factors-combined with a focus on early intervention, preventive care, and non-invasive treatment options-are cementing the role of anti-embolism stockings as a fundamental component of modern healthcare systems around the world.

SCOPE OF STUDY:

The report analyzes the Anti-Embolism Stockings market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Calf-Length Anti-Embolism Stockings, Thigh-Length Anti-Embolism Stockings); Demography (Men, Women); End-Use (Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• 3M Company
• B. Braun Melsungen AG
• BSN Medical GmbH
• Cardinal Health Inc.
• Covidien (Medtronic)
• Essity AB
• Halyard Health Inc.
• Kendall (Covidien)
• Lohmann & Rauscher GmbH
• Medline Industries, Inc.
• Molnlycke Health Care AB
• Paul Hartmann AG
• Prestige Brands Holdings Inc.
• Sanko Medical Co., Ltd.
• Sigvaris AG
• Smith & Nephew plc
• Solidea S.r.l.
• Thermo Fisher Scientific Inc.
• Thuasne Group
• Unomedical (a part of Coloplast)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Anti-Embolism Stockings - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Surgical and Postoperative Complication Awareness Throws the Spotlight on Anti-Embolism Stockings
  • Use in DVT Prevention Among Hospitalized and Immobile Patients Drives Demand
  • OEMs Offering Graduated Compression Stockings With Improved Comfort Enhance Wearability
  • Expansion of Preventive Protocols in Orthopedic, Cardiac, and Cancer Surgeries Spurs Market Uptake
  • Rising Elderly and Postpartum Populations Support Broad-Based Prophylactic Use
  • OEMs Emphasizing Latex-Free, Breathable, and Skin-Friendly Fabrics Improve Patient Compliance
  • Growth in Long-Distance Travel and Air Travel Health Awareness Supports Consumer-Grade Adoption
  • Integration With Smart Monitoring Wearables for Circulation Adds Technological Edge
  • Use in Homecare and Outpatient Recovery Strengthens Demand for Over-the-Counter Stockings
  • OEMs Offering Size-Variant and Adjustable Designs Enhance Personalization and Fit
  • Increased Emphasis on Fall Prevention and Mobility Support Expands Multifunctional Use
  • Growing Institutional Adoption in ICU and Rehabilitation Centers Drives Bulk Procurement
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Anti-Embolism Stockings Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Calf-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Calf-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thigh-Length Anti-Embolism Stockings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Thigh-Length Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Men by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Women by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Post-operative Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Post-operative Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pregnant Women End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pregnant Women End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Anti-Embolism Stockings by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Anti-Embolism Stockings by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Anti-Embolism Stockings by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Anti-Embolism Stockings by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Anti-Embolism Stockings by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Anti-Embolism Stockings Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Anti-Embolism Stockings by Product - Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Anti-Embolism Stockings by Product - Percentage Breakdown of Value Sales for Calf-Length Anti-Embolism Stockings and Thigh-Length Anti-Embolism Stockings for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by Demography - Men and Women - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Anti-Embolism Stockings by Demography - Men and Women Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Anti-Embolism Stockings by Demography - Percentage Breakdown of Value Sales for Men and Women for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Anti-Embolism Stockings by End-Use - Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Anti-Embolism Stockings by End-Use - Percentage Breakdown of Value Sales for Ambulatory Patients End-Use, Post-operative Patients End-Use, Pregnant Women End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION